[DOI] [PubMed] [Google Scholar] 108.Frye R.E., Lionnard L., Singh I., Karim M.A., Chajra H., Frechet M., Kissa K., Racine V., Ammanamanchi A., McCarty P.J., et al
Low-Income Subsidy (Extra Help) cost-sharing also doesnt apply, so even beneficiaries who normally pay $0 will pay the flat $50 here
These are stated timelines, not guarantees
In that regard, actual market dominance appears to be significantly driven by simplicity of use, dosing schedule, injection site discomfort, robust efficacy, indication and contraindication in certain subpopulations, and low side-effect profile along with non-scientific factors, such as first-to-market, size and experience of the companys diabetes sales force, negotiated pricing and reimbursement agreement, geographic areas of regulatory approvals and patent exclusivity
Always consult your treating physician before using this supplement if you have any hepatic or renal condition